Crux Wealth Advisors Invests $983,000 in UnitedHealth Group Incorporated (NYSE:UNH)

Crux Wealth Advisors bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 1,943 shares of the healthcare conglomerate's stock, valued at approximately $983,000.

A number of other institutional investors also recently bought and sold shares of UNH. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $25,000. Hurley Capital LLC purchased a new position in UnitedHealth Group in the fourth quarter worth about $28,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter worth approximately $30,000. Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group during the fourth quarter valued at approximately $30,000. Finally, Promus Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $32,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Down 2.2 %

Shares of UNH stock traded down $13.24 on Monday, reaching $586.23. 4,838,165 shares of the company's stock were exchanged, compared to its average volume of 4,346,637. UnitedHealth Group Incorporated has a 52 week low of $438.50 and a 52 week high of $630.73. The stock has a market capitalization of $536.23 billion, a PE ratio of 37.82, a P/E/G ratio of 1.37 and a beta of 0.61. The company's fifty day simple moving average is $512.87 and its 200 day simple moving average is $541.80. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the business posted $5.83 EPS. The firm's revenue for the quarter was up 6.8% on a year-over-year basis. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.43%. UnitedHealth Group's dividend payout ratio is currently 54.19%.

Analyst Upgrades and Downgrades

A number of analysts have commented on the company. Hsbc Global Res upgraded UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. HSBC raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price objective for the company in a research note on Friday, January 10th. Truist Financial upped their target price on shares of UnitedHealth Group from $610.00 to $660.00 and gave the stock a "buy" rating in a report on Friday. Barclays lowered their price objective on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research report on Friday, January 17th. Finally, Piper Sandler lowered their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. Twenty-one research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $632.85.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm's stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.